CHRS Stock Price Prediction
-
$
0.000
1-Day-Price-Prediction
-0.47%
1-Week Prediction
+0.77%
Based on our advanced algorithm, we predict that CHRS stock price will experience significant movement in the coming periods. Our 1-day prediction estimates a price of $1.24, while the 1-week outlook suggests a value of $1.24. For the 1-month forecast, we project a price of $1.28. Looking further ahead, our 2026 projection estimates a value of $0.70, with a long-term 2030 forecast reaching $0.25. Stay informed and make strategic decisions with our data-driven insights!
Should I Buy Coherus Oncology Inc Stock?
Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. CHRS has several negative signals and is within a falling trend, so we believe it will perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Our analysis conclusion for this stock is a Strong Sell candidate.
CHRS stock price ended at $1.23 on Thursday, after rising 0.82%
The Coherus Oncology Inc stock price increased by 0.82% on the last trading day (04 Dec 2025), rising from 1.22 to 1.23. Throughout the last trading session, the stock experienced a fluctuation of 4.17% , ranging from a day low of $1.2 to a day high of 1.25. The price has declined in 3 of the last 10 days, resulting in a total change of 6.03% during this period. On the last day, trading volume decrease by -159.67K shares, with the rising prices. This could serve as an early warning, indicating that risk may slightly increase in the coming days. In total, 831.12K shares were traded, amounting to approximately 1.02M.
CHRS Technical Signals
CHRS(Coherus Oncology Inc Corp) has 1 buy signal and 2 sell signals now. The current trend is a downtrend starting from 2025-11-18. The total price change during this trend is +1.65%. Recently, the price has dropped while volume droped, indicating a potential rebound signal. The average turnover of CHRS over the last 5 trading days is 1.07M. Overall, the technical indicator signals lean more toward a Neutral outlook in the mid-term.
CHRS Moving Average Analysis
Coherus Oncology Inc's overall moving average trend leans more bearish as of Friday, December 5, 2025, with 3 negative signals and 1 positive signal. In the mid-term, the SMA_20 being below the SMA_60 signals a strong bearish trend. There will be some resistance from the lines at $1.42, and $1.53. A break-up above any of these levels will issue buy signals. There will be some support from the lines at $1.06, and $0.94. A break-down below any of these levels will issue sell signals.
CHRS Short Selling Analysis
The short sale ratio of Coherus Oncology Inc(CHRS) as of 03 Dec 2025 is 30.85%, rising from last trading day. With increasing price from 1.16 to 1.22. The short sell activity indicate that short sellers may be anticipating a price reversion.
Technical Signal
Technical Signals Summary
Sell
2
Buy
1
Moving Average
Swing
NegativeStock Price Below SMA_5
Short Term
NegativeSMA_5 Below SMA_20
Mid Term
NegativeSMA_20 Below SMA_60
Long Term
PositiveSMA_60 Above SMA_200
Short Selling
Close Price
Short Sale Ratio
Short Sale Volume
1 Bullish Signals
When Value satisfies Signal, Indicator signals Bullish
Indicators
Signal
Value
Meaning
Momentum (10 days)
MOM_10 > 0
0.07
Bullish
2 Bearish Signals
When Value satisfies Signal, Indicator signals Bearish
Indicators
Signal
Value
Meaning
Awesome Oscillator (5, 34)
AO_5_34 < 0
-0.167
Bearish
Moving Average Convergence Divergence (12, 26, 9)
MACD_12_26_9 < 0
-0.074
Bearish
CHRS Stock Forecast
2026
2027
2028
2029
2030
2031
2032
2033
2034
2035
In 2026, Coherus Oncology Inc (CHRS) is anticipated to change hands in a trading channel between $0.41 and $0.90.
Coherus Oncology Inc Stock Forecast 2026
Jan 2026: CHRS Stock Forecast
Potential ROI: -0.85%
In Jan 2026, Coherus Oncology Inc's value is forecasted to reach an average price of $0.71. The price is predicted to fluctuate between a low of $0.71 and a high of $0.87.
Feb 2026: CHRS Stock Forecast
Potential ROI: -27.24%
In Feb 2026, Coherus Oncology Inc's value is forecasted to reach an average price of $0.52. The price is predicted to fluctuate between a low of $0.41 and a high of $0.54.
Mar 2026: CHRS Stock Forecast
Potential ROI: 2.24%
In Mar 2026, Coherus Oncology Inc's value is forecasted to reach an average price of $0.74. The price is predicted to fluctuate between a low of $0.69 and a high of $0.78.
Apr 2026: CHRS Stock Forecast
Potential ROI: -16.71%
In Apr 2026, Coherus Oncology Inc's value is forecasted to reach an average price of $0.60. The price is predicted to fluctuate between a low of $0.46 and a high of $0.65.
May 2026: CHRS Stock Forecast
Potential ROI: -11.38%
In May 2026, Coherus Oncology Inc's value is forecasted to reach an average price of $0.64. The price is predicted to fluctuate between a low of $0.50 and a high of $0.75.
Jun 2026: CHRS Stock Forecast
Potential ROI: -27.24%
In Jun 2026, Coherus Oncology Inc's value is forecasted to reach an average price of $0.52. The price is predicted to fluctuate between a low of $0.46 and a high of $0.52.
Jul 2026: CHRS Stock Forecast
Potential ROI: -14.44%
In Jul 2026, Coherus Oncology Inc's value is forecasted to reach an average price of $0.62. The price is predicted to fluctuate between a low of $0.61 and a high of $0.67.
Aug 2026: CHRS Stock Forecast
Potential ROI: -19.88%
In Aug 2026, Coherus Oncology Inc's value is forecasted to reach an average price of $0.58. The price is predicted to fluctuate between a low of $0.50 and a high of $0.59.
Sep 2026: CHRS Stock Forecast
Potential ROI: -15.43%
In Sep 2026, Coherus Oncology Inc's value is forecasted to reach an average price of $0.61. The price is predicted to fluctuate between a low of $0.46 and a high of $0.72.
Oct 2026: CHRS Stock Forecast
Potential ROI: 2.24%
In Oct 2026, Coherus Oncology Inc's value is forecasted to reach an average price of $0.74. The price is predicted to fluctuate between a low of $0.65 and a high of $0.90.
Nov 2026: CHRS Stock Forecast
Potential ROI: -10.41%
In Nov 2026, Coherus Oncology Inc's value is forecasted to reach an average price of $0.65. The price is predicted to fluctuate between a low of $0.63 and a high of $0.72.
Dec 2026: CHRS Stock Forecast
Potential ROI: -2.49%
In Dec 2026, Coherus Oncology Inc's value is forecasted to reach an average price of $0.70. The price is predicted to fluctuate between a low of $0.58 and a high of $0.75.
CHRS Price Prediction & Forecast by Similar Chart Analysis
Based on historical patterns and backtesting of stocks with similar movements to Coherus Oncology Inc(CHRS), our algorithm predicts CHRS's 1-month price at $1.13, with an -17.15%downwardshift. Using a similarity score up to 97.87%and other factors, This forecast updates weekly, adjusting for significant deviations.
Similar Chart
The price prediction chart for Coherus Oncology Inc (CHRS.O) stock, as of Monday, December 1, 2025 , forecasts a -17.15% change over the next month, based on its high correlation with RVSB.O stock patterns. The similarity between their price movements over the analyzed periods is 97.87%. The right panel lists other stocks with similar price patterns. This prediction is updated every week.
CHRS
No Data
RVSB
Down: -17.15%Similarity: 97.87%
Name
Similarity
Up/Down
RVSB.O
97.87%
-17.15%
WST.N
97.85%
-23.86%
CMBT.N
97.84%
+7.27%
TTSH.O
97.84%
+26.44%
OBK.N
97.77%
-6.71%
ANGO.O
97.77%
+7.62%
SKM.N
97.75%
+4.58%
GNLN.O
97.69%
-3.08%
LVS.N
97.58%
+3.53%
TFX.N
97.56%
-15.16%
CHRS Seasonality Analysis
Based on CHRS's historical stock price data across all years, the probability of a positive return in December is45.45%, suggesting it maynotbe an ideal month to invest in CHRS. In contrast,Augustoffers the highest probability of positive returns at81.82%, making it a potentially strong month for investment.
However, this is only a prediction based on one method, and a comprehensive assessment of the stock's future trend should consider additional factors. Our final stock price commentary incorporates three main evaluation dimensions: technical signals, Moving Average trends, and similar chart pattern matching, with the first two dimensions carrying the primary weight to ensure a more robust and accurate forecast.
Monthly Seasonality
The radar chart shows that buying Coherus Oncology Inc (CHRS.O) stock in August has the highest probability of a positive return (81.82%), while September has the lowest probability (18.18%).
Performance Seasonality
The chart shows Coherus Oncology Inc. (CHRS)'s annual stock price return for the past three years, helping you analyze price trends and identify recurring trends on an annual basis.
People Also Watch
FAQ
Should I buy Coherus Oncology Inc (CHRS.O) stock?
Which months have the highest win rate for buying Coherus Oncology Inc (CHRS.O) stock in a year?
How has Coherus Oncology Inc. (CHRS)'s stock price performed over the past three years?
Which bullish technical signals does CHRS have?
Which bearish technical signals does CHRS have?
Is CHRS a buy based on overall technical signals summary?
What is the trend of Coherus Oncology Inc (CHRS)'s moving average?
What is price prediction for CHRS stock next month?
What is price prediction 2026 for Coherus Oncology Inc (CHRS) Stock?